Becton DickinsonBDXEarnings & Financial Report
Becton, Dickinson and Company is an American multinational medical technology company that manufactures and sells medical devices, instrument systems, and reagents. BD also provides consulting and analytics services in certain areas.
BDX Q1 2026 Key Financial Metrics
Revenue
$5.3B
Gross Profit
$2.4B
Operating Profit
$552.0M
Net Profit
$382.0M
Gross Margin
45.9%
Operating Margin
10.5%
Net Margin
7.3%
YoY Growth
-0.4%
EPS
$1.34
Financial Flow
Becton Dickinson Q1 2026 Financial Summary
Becton Dickinson reported revenue of $5.3B for Q1 2026, with a net profit of $382.0M (7.3% margin). Cost of goods sold was $2.8B, operating expenses totaled $1.9B.
Key Financial Metrics
| Total Revenue | $5.3B |
|---|---|
| Net Profit | $382.0M |
| Gross Margin | 45.9% |
| Operating Margin | 10.5% |
| Report Period | Q1 2026 |
Becton Dickinson Annual Revenue by Year
Becton Dickinson annual revenue history includes year-by-year totals (for example, 2025 revenue was $21.5B).
| Year | Annual Revenue |
|---|---|
| 2025 | $21.5B |
| 2024 | $20.2B |
| 2023 | $19.3B |
| 2022 | $18.9B |
Income Statement
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.99B | $4.99B | $5.17B | $5.27B | $5.51B | $5.51B | $5.25B | $5.25B |
| YoY Growth | 2.3% | 2.3% | 9.8% | 4.5% | 10.4% | 10.4% | 1.6% | -0.4% |
Balance Sheet
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $55.58B | $57.29B | $54.66B | $54.47B | $54.90B | $55.33B | $54.84B | $54.84B |
| Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Equity | $25.87B | $25.89B | $25.20B | $25.24B | $25.47B | $25.39B | $25.28B | $25.28B |
Cash Flow
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $1.30B | $1.18B | $693.0M | $164.0M | $1.22B | $1.35B | $657.0M | $657.0M |
Other Health Care Companies
ABT
Abbott Laboratories
Revenue
$11.4B
Net Profit
$1.6B
BAX
Baxter International
Revenue
$3.0B
Net Profit
$-1.1B
BSX
Boston Scientific
Revenue
$5.3B
Net Profit
$670.0M
DXCM
Dexcom
Revenue
$1.3B
Net Profit
$267.3M
EW
Edwards Lifesciences
Revenue
$1.6B
Net Profit
$291.1M
GEHC
GE HealthCare
Revenue
$5.7B
Net Profit
$588.0M
HOLX
Hologic
Revenue
$1.0B
Net Profit
$179.1M
IDXX
Idexx Laboratories
Revenue
$1.1B
Net Profit
$274.6M
PODD
Insulet Corporation
Revenue
$783.7M
Net Profit
$101.6M
ISRG
Intuitive Surgical
Revenue
$2.9B
Net Profit
$794.8M